US5605798A
(en)
|
1993-01-07 |
1997-02-25 |
Sequenom, Inc. |
DNA diagnostic based on mass spectrometry
|
WO1994016101A2
(en)
|
1993-01-07 |
1994-07-21 |
Koester Hubert |
Dna sequencing by mass spectrometry
|
US6194144B1
(en)
|
1993-01-07 |
2001-02-27 |
Sequenom, Inc. |
DNA sequencing by mass spectrometry
|
US6146854A
(en)
*
|
1995-08-31 |
2000-11-14 |
Sequenom, Inc. |
Filtration processes, kits and devices for isolating plasmids
|
WO1997033000A1
(en)
|
1996-03-04 |
1997-09-12 |
Genetrace Systems, Inc. |
Methods of screening nucleic acids using mass spectrometry
|
US6214555B1
(en)
*
|
1996-05-01 |
2001-04-10 |
Visible Genetics Inc. |
Method compositions and kit for detection
|
US6022688A
(en)
|
1996-05-13 |
2000-02-08 |
Sequenom, Inc. |
Method for dissociating biotin complexes
|
US5777324A
(en)
|
1996-09-19 |
1998-07-07 |
Sequenom, Inc. |
Method and apparatus for maldi analysis
|
US5965363A
(en)
|
1996-09-19 |
1999-10-12 |
Genetrace Systems Inc. |
Methods of preparing nucleic acids for mass spectrometric analysis
|
US7285422B1
(en)
|
1997-01-23 |
2007-10-23 |
Sequenom, Inc. |
Systems and methods for preparing and analyzing low volume analyte array elements
|
US6133436A
(en)
|
1996-11-06 |
2000-10-17 |
Sequenom, Inc. |
Beads bound to a solid support and to nucleic acids
|
US6140053A
(en)
*
|
1996-11-06 |
2000-10-31 |
Sequenom, Inc. |
DNA sequencing by mass spectrometry via exonuclease degradation
|
CA2270132A1
(en)
*
|
1996-11-06 |
1998-05-14 |
Sequenom, Inc. |
Dna diagnostics based on mass spectrometry
|
AU5794498A
(en)
|
1996-12-10 |
1998-07-03 |
Genetrace Systems, Inc. |
Releasable nonvolatile mass-label molecules
|
DE19653494A1
(de)
*
|
1996-12-20 |
1998-06-25 |
Svante Dr Paeaebo |
Verfahren zur entkoppelten, direkten, exponentiellen Amplifikation und Sequenzierung von DNA Molekülen unter Zugabe einer zweiten thermostabilen DNA Polymerase und dessen Anwendung
|
US6399304B1
(en)
|
1996-12-20 |
2002-06-04 |
Roche Diagnostics Gmbh |
Sequential activation of one or more enzymatic activities within a thermocycling reaction for synthesizing DNA molecules
|
DE19653439A1
(de)
*
|
1996-12-20 |
1998-07-02 |
Svante Dr Paeaebo |
Verfahren zur direkten, exponentiellen Amplifikation und Sequenzierung von DNA Molekülen und dessen Anwendung
|
US6828094B2
(en)
*
|
1996-12-20 |
2004-12-07 |
Roche Diagnostics Gmbh |
Method for the uncoupled, direct, exponential amplification and sequencing of DNA molecules with the addition of a second thermostable DNA polymerase and its application
|
US6265193B1
(en)
|
1997-03-12 |
2001-07-24 |
Pe Corporation (Ny) |
DNA polymerases having improved labeled nucleotide incorporation properties
|
US6207370B1
(en)
|
1997-09-02 |
2001-03-27 |
Sequenom, Inc. |
Diagnostics based on mass spectrometric detection of translated target polypeptides
|
US20110166040A1
(en)
*
|
1997-09-05 |
2011-07-07 |
Ibis Biosciences, Inc. |
Compositions for use in identification of strains of e. coli o157:h7
|
AU3534199A
(en)
*
|
1998-04-23 |
1999-11-08 |
Takara Shuzo Co., Ltd. |
Method For Synthesizing DNA
|
US7875440B2
(en)
|
1998-05-01 |
2011-01-25 |
Arizona Board Of Regents |
Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
|
US6780591B2
(en)
|
1998-05-01 |
2004-08-24 |
Arizona Board Of Regents |
Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
|
US20040121394A1
(en)
*
|
1998-08-19 |
2004-06-24 |
Dawson Elliott P. |
Method for determining polynucleotide sequence variations
|
US20030138834A1
(en)
*
|
1998-08-19 |
2003-07-24 |
Dawson Elliott P. |
Method for determining polynucleotide sequence variations
|
WO2000011221A1
(en)
*
|
1998-08-19 |
2000-03-02 |
Bioventures, Inc. |
Method for determining polynucleotide sequence variations
|
ATE439437T1
(de)
*
|
1999-01-05 |
2009-08-15 |
Univ Boston |
Verbessertes klonierungsverfahren
|
US6225061B1
(en)
|
1999-03-10 |
2001-05-01 |
Sequenom, Inc. |
Systems and methods for performing reactions in an unsealed environment
|
AU775179B2
(en)
|
1999-03-15 |
2004-07-22 |
Applied Biosystems, Llc |
Probe/mobility modifier complexes for multiplex nucleic acid detection
|
US20020009394A1
(en)
|
1999-04-02 |
2002-01-24 |
Hubert Koster |
Automated process line
|
WO2000073764A2
(en)
|
1999-06-01 |
2000-12-07 |
Baylor College Of Medicine |
Composition and methods for the therapeutic use of an atonal-associated sequence
|
US7501245B2
(en)
|
1999-06-28 |
2009-03-10 |
Helicos Biosciences Corp. |
Methods and apparatuses for analyzing polynucleotide sequences
|
US6942964B1
(en)
*
|
1999-07-09 |
2005-09-13 |
Sigma-Aldrich Co. |
Tracer reagents that enhance reaction-product analysis
|
US20020045182A1
(en)
*
|
1999-07-16 |
2002-04-18 |
Lynx Therapeutics, Inc. |
Multiplexed differential displacement for nucleic acid determinations
|
JP2003510063A
(ja)
*
|
1999-09-30 |
2003-03-18 |
ニュー・イングランド・バイオラブズ・インコーポレイティッド |
古細菌のdnaポリメラーゼによる修飾ヌクレオチドの取り込み及びそれに関する方法
|
US20030190644A1
(en)
|
1999-10-13 |
2003-10-09 |
Andreas Braun |
Methods for generating databases and databases for identifying polymorphic genetic markers
|
US20030207297A1
(en)
*
|
1999-10-13 |
2003-11-06 |
Hubert Koster |
Methods for generating databases and databases for identifying polymorphic genetic markers
|
KR20020064298A
(ko)
|
1999-10-13 |
2002-08-07 |
시쿼넘, 인코포레이티드 |
다형성 유전 마커를 동정하기 위한 데이타베이스 및 이의제조 방법
|
US7917301B1
(en)
|
2000-09-19 |
2011-03-29 |
Sequenom, Inc. |
Method and device for identifying a biological sample
|
CN1336960A
(zh)
*
|
1999-11-26 |
2002-02-20 |
株式会社百尼尔 |
采用多种dna聚合酶的dna测序方法和所用的试剂盒
|
DE10010282B4
(de)
|
2000-02-25 |
2006-11-16 |
Epigenomics Ag |
Verfahren zur Detektion von Cytosin-Methylierung in DNA Proben
|
DE60137722D1
(de)
|
2000-06-13 |
2009-04-02 |
Univ Boston |
Verwendung von mass-matched nukleotide in der analyse von oligonukleotidmischungen sowie in der hoch-multiplexen nukleinsäuresequenzierung
|
WO2002004511A2
(en)
|
2000-07-10 |
2002-01-17 |
Board Of Regents, The University Of Texas System |
CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
|
GB0021286D0
(en)
*
|
2000-08-30 |
2000-10-18 |
Gemini Genomics Ab |
Identification of drug metabolic capacity
|
AU2002245047A1
(en)
|
2000-10-30 |
2002-07-24 |
Sequenom, Inc. |
Method and apparatus for delivery of submicroliter volumes onto a substrate
|
US7575924B2
(en)
|
2000-11-13 |
2009-08-18 |
Research Development Foundation |
Methods and compositions relating to improved lentiviral vectors and their applications
|
DE60224383T3
(de)
|
2001-02-15 |
2012-06-28 |
The University Of Chicago |
Verfahren zum nachweis in hefe für mittel die proteinfaltung beeinflussen
|
US7226739B2
(en)
|
2001-03-02 |
2007-06-05 |
Isis Pharmaceuticals, Inc |
Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
|
US7666588B2
(en)
|
2001-03-02 |
2010-02-23 |
Ibis Biosciences, Inc. |
Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
|
US7718354B2
(en)
|
2001-03-02 |
2010-05-18 |
Ibis Biosciences, Inc. |
Methods for rapid identification of pathogens in humans and animals
|
US20040121314A1
(en)
*
|
2002-12-06 |
2004-06-24 |
Ecker David J. |
Methods for rapid detection and identification of bioagents in containers
|
US20040121310A1
(en)
*
|
2002-12-18 |
2004-06-24 |
Ecker David J. |
Methods for rapid detection and identification of bioagents in forensic studies
|
US20040121335A1
(en)
|
2002-12-06 |
2004-06-24 |
Ecker David J. |
Methods for rapid detection and identification of bioagents associated with host versus graft and graft versus host rejections
|
US20030027135A1
(en)
*
|
2001-03-02 |
2003-02-06 |
Ecker David J. |
Method for rapid detection and identification of bioagents
|
US7297518B2
(en)
*
|
2001-03-12 |
2007-11-20 |
California Institute Of Technology |
Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension
|
US20020155587A1
(en)
|
2001-04-20 |
2002-10-24 |
Sequenom, Inc. |
System and method for testing a biological sample
|
US7217510B2
(en)
|
2001-06-26 |
2007-05-15 |
Isis Pharmaceuticals, Inc. |
Methods for providing bacterial bioagent characterizing information
|
US8073627B2
(en)
|
2001-06-26 |
2011-12-06 |
Ibis Biosciences, Inc. |
System for indentification of pathogens
|
DE10132785A1
(de)
*
|
2001-07-06 |
2003-01-16 |
Clondiag Chip Tech Gmbh |
Verfahren zum Nachweis von in einer Polymerase-Kettenreaktion amplifizierten Nukleinsäuremolekülen
|
CA2453434C
(en)
*
|
2001-07-16 |
2009-04-14 |
Hk Pharmaceuticals, Inc. |
Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
|
WO2003012054A2
(en)
|
2001-08-02 |
2003-02-13 |
Institut Clayton De La Recherche |
Methods and compositions relating to improved lentiviral vector production systems
|
AU2002324909A1
(en)
*
|
2001-09-07 |
2003-03-24 |
Baylor College Of Medicine |
Linear dna fragments for gene expression
|
US20050042629A1
(en)
|
2002-09-13 |
2005-02-24 |
Applera Corporation |
Thermus scotoductus nucleic acid polymerases
|
KR20040054699A
(ko)
|
2001-10-02 |
2004-06-25 |
엥스띠뛰 끌레이톤 드 라 러쉐르쉬 |
제한된 발현의 렌티바이러스 벡터 및 이의 적용과 관련된방법 및 조성물
|
US20030170678A1
(en)
*
|
2001-10-25 |
2003-09-11 |
Neurogenetics, Inc. |
Genetic markers for Alzheimer's disease and methods using the same
|
AU2002364945A1
(en)
*
|
2001-10-25 |
2003-07-09 |
Neurogenetics, Inc. |
Genes and polymorphisms on chromosome 10 associated with alzheimer's disease and other neurodegenerative diseases
|
US20030224380A1
(en)
*
|
2001-10-25 |
2003-12-04 |
The General Hospital Corporation |
Genes and polymorphisms on chromosome 10 associated with Alzheimer's disease and other neurodegenerative diseases
|
EP1451674A4
(de)
*
|
2001-10-26 |
2008-08-20 |
Sequenom Inc |
Verfahren und vorrichtung zur parallelen ausgabe definierter volumen von festpartikeln
|
AU2002348417B9
(en)
|
2001-10-26 |
2010-02-04 |
Baylor College Of Medicine |
A composition and method to alter lean body mass and bone properties in a subject
|
EP1483378B1
(de)
*
|
2001-11-02 |
2013-01-02 |
Rice University |
Recycling-system zur manipulation intrazellulärer nadh-verfügbarkeit
|
US7052877B2
(en)
|
2001-11-30 |
2006-05-30 |
Applera Corporation |
Thermus brockianus nucleic acid polymerases
|
EP1465654B1
(de)
|
2001-12-11 |
2015-02-25 |
Inovio Pharmaceuticals, Inc. |
Durch plasmid übertragene supplementierung zur behandlung chronisch kranker patienten
|
WO2003064621A2
(en)
|
2002-02-01 |
2003-08-07 |
Ambion, Inc. |
HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
|
EP3415625A1
(de)
|
2002-02-01 |
2018-12-19 |
Life Technologies Corporation |
Doppelsträngige oligonukleotide
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
US20030228589A1
(en)
*
|
2002-02-12 |
2003-12-11 |
Bond-Nutter Diane R. |
Polymerase compositions
|
ATE421088T1
(de)
*
|
2002-03-11 |
2009-01-15 |
Caprotec Bioanalytics Gmbh |
Verbindungen und verfahren für die analyse des proteoms
|
EP1499736B1
(de)
*
|
2002-04-26 |
2009-03-04 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Verbesserte chimäre glykoproteine und pseudotypisierte lentivirale vektoren
|
CN100543036C
(zh)
|
2002-05-06 |
2009-09-23 |
得克萨斯州大学系统董事会 |
递送治疗或诊断试剂的导向蛋白质
|
US20030220844A1
(en)
*
|
2002-05-24 |
2003-11-27 |
Marnellos Georgios E. |
Method and system for purchasing genetic data
|
WO2003101177A2
(en)
*
|
2002-06-04 |
2003-12-11 |
Sequenom, Inc. |
Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions
|
WO2004002296A2
(en)
*
|
2002-06-27 |
2004-01-08 |
Sequenom, Inc. |
Therapeutic methods for reducing fat deposition and treating associated conditions
|
AU2003248793A1
(en)
*
|
2002-06-27 |
2004-01-19 |
Sequenom, Inc |
Diagnosing predisposition to fat deposition and associated condition
|
JP4570565B2
(ja)
|
2002-07-15 |
2010-10-27 |
ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム |
ペリプラズム発現によるコンビナトリアルタンパク質ライブラリーのスクリーニング
|
US20050042646A1
(en)
*
|
2002-08-05 |
2005-02-24 |
Davidson Beverly L. |
RNA interference suppresion of neurodegenerative diseases and methods of use thereof
|
US20040241854A1
(en)
|
2002-08-05 |
2004-12-02 |
Davidson Beverly L. |
siRNA-mediated gene silencing
|
US20050255086A1
(en)
*
|
2002-08-05 |
2005-11-17 |
Davidson Beverly L |
Nucleic acid silencing of Huntington's Disease gene
|
US20050106731A1
(en)
*
|
2002-08-05 |
2005-05-19 |
Davidson Beverly L. |
siRNA-mediated gene silencing with viral vectors
|
US20040023390A1
(en)
*
|
2002-08-05 |
2004-02-05 |
Davidson Beverly L. |
SiRNA-mediated gene silencing with viral vectors
|
US20080274989A1
(en)
|
2002-08-05 |
2008-11-06 |
University Of Iowa Research Foundation |
Rna Interference Suppression of Neurodegenerative Diseases and Methods of Use Thereof
|
US20080176812A1
(en)
*
|
2002-08-05 |
2008-07-24 |
Davidson Beverly L |
Allele-specific silencing of disease genes
|
EP2269618A1
(de)
|
2002-08-12 |
2011-01-05 |
Jennerex Biotherapeutics ULC |
Ein onkolytisches Vaccinia-Virus zur Verwendung in Kombination mit Chemotherapie zur Behandlung von Krebs
|
US20040109853A1
(en)
*
|
2002-09-09 |
2004-06-10 |
Reactive Surfaces, Ltd. |
Biological active coating components, coatings, and coated surfaces
|
US20050277118A1
(en)
*
|
2002-09-11 |
2005-12-15 |
Roth Richard B |
Methods for identifying subjects at risk of melanoma and treatments thereof
|
CA2504903A1
(en)
*
|
2002-11-06 |
2004-05-27 |
Sequenom, Inc. |
Method for identifying risk of melanoma and treatments thereof
|
DK1563069T3
(da)
*
|
2002-11-22 |
2012-07-23 |
Inst Clayton De La Rech |
Sammensætninger og systemer til genregulering
|
AU2003293130A1
(en)
*
|
2002-11-25 |
2004-06-18 |
Sequenom, Inc. |
Methods for identifying risk of breast cancer and treatments thereof
|
US20060204967A1
(en)
*
|
2002-11-25 |
2006-09-14 |
Roth Richard B |
Methods for identifying risk of breast cancer and treatments thereof
|
US20050118606A1
(en)
*
|
2002-11-25 |
2005-06-02 |
Roth Richard B. |
Methods for identifying risk of breast cancer and treatments thereof
|
EP2112229A3
(de)
|
2002-11-25 |
2009-12-02 |
Sequenom, Inc. |
Verfahren zum Identifizieren des Brustkrebsrisikos und zugehörige Behandlungen
|
WO2004050839A2
(en)
*
|
2002-11-27 |
2004-06-17 |
Sequenom, Inc. |
Fragmentation-based methods and systems for sequence variation detection and discovery
|
EP1578399A4
(de)
|
2002-12-06 |
2007-11-28 |
Isis Pharmaceuticals Inc |
Verfahren für die rasche identifikation von pathogenen bei tier und mensch
|
WO2004064972A2
(en)
*
|
2003-01-16 |
2004-08-05 |
Hk Pharmaceuticals, Inc. |
Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
|
US7312202B2
(en)
|
2003-02-18 |
2007-12-25 |
Board Of Regents, The University Of Texas System |
Rationally designed and chemically synthesized promoter for genetic vaccine and gene therapy
|
CA2557737C
(en)
|
2003-03-12 |
2014-08-05 |
Advisys, Inc. |
Insulin-like growth factor (igf-i) plasmid-mediated supplementation for therapeutic applications
|
US8046171B2
(en)
|
2003-04-18 |
2011-10-25 |
Ibis Biosciences, Inc. |
Methods and apparatus for genetic evaluation
|
TW200424214A
(en)
*
|
2003-04-21 |
2004-11-16 |
Advisys Inc |
Plasmid mediated GHRH supplementation for renal failures
|
US20050009053A1
(en)
*
|
2003-04-25 |
2005-01-13 |
Sebastian Boecker |
Fragmentation-based methods and systems for de novo sequencing
|
US8057993B2
(en)
|
2003-04-26 |
2011-11-15 |
Ibis Biosciences, Inc. |
Methods for identification of coronaviruses
|
US7964343B2
(en)
|
2003-05-13 |
2011-06-21 |
Ibis Biosciences, Inc. |
Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
|
US8158354B2
(en)
|
2003-05-13 |
2012-04-17 |
Ibis Biosciences, Inc. |
Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
|
US7572581B2
(en)
*
|
2003-06-30 |
2009-08-11 |
Roche Molecular Systems, Inc. |
2′-terminator nucleotide-related methods and systems
|
US20070224615A1
(en)
*
|
2003-07-09 |
2007-09-27 |
Invitrogen Corporation |
Methods for assaying protein-protein interactions
|
EP2336768A1
(de)
|
2003-07-09 |
2011-06-22 |
Life Technologies Corporation |
Verfahren zum testen einer Protein-Protein-Wechselwirkung
|
US20050233341A1
(en)
*
|
2003-07-23 |
2005-10-20 |
Roth Richard R |
Methods for identifying risk of melanoma and treatments thereof
|
WO2005014846A2
(en)
*
|
2003-07-24 |
2005-02-17 |
Sequenom, Inc. |
Methods for identifying risk of breast cancer and treatments thereof
|
US20050059024A1
(en)
|
2003-07-25 |
2005-03-17 |
Ambion, Inc. |
Methods and compositions for isolating small RNA molecules
|
CN1882688B
(zh)
|
2003-07-25 |
2014-07-16 |
安比恩股份有限公司 |
用于分离小rna分子的方法和组合物
|
EP2107129B1
(de)
|
2003-07-31 |
2012-08-22 |
Sequenom, Inc. |
Verfahren für Multiplex-Polymerasekettenreaktionen auf hohem Niveau und homogene Massenausdehnungsreaktionen zur Genotypisierung von Polymorphismen
|
AU2003269991A1
(en)
*
|
2003-08-20 |
2005-03-10 |
Applera Corporation |
Polymerase compositions
|
US9394565B2
(en)
*
|
2003-09-05 |
2016-07-19 |
Agena Bioscience, Inc. |
Allele-specific sequence variation analysis
|
US8097416B2
(en)
|
2003-09-11 |
2012-01-17 |
Ibis Biosciences, Inc. |
Methods for identification of sepsis-causing bacteria
|
US8242254B2
(en)
|
2003-09-11 |
2012-08-14 |
Ibis Biosciences, Inc. |
Compositions for use in identification of bacteria
|
US8546082B2
(en)
|
2003-09-11 |
2013-10-01 |
Ibis Biosciences, Inc. |
Methods for identification of sepsis-causing bacteria
|
US20100129811A1
(en)
*
|
2003-09-11 |
2010-05-27 |
Ibis Biosciences, Inc. |
Compositions for use in identification of pseudomonas aeruginosa
|
US7169560B2
(en)
|
2003-11-12 |
2007-01-30 |
Helicos Biosciences Corporation |
Short cycle methods for sequencing polynucleotides
|
US8163895B2
(en)
|
2003-12-05 |
2012-04-24 |
Ibis Biosciences, Inc. |
Compositions for use in identification of orthopoxviruses
|
WO2005073409A2
(en)
*
|
2004-01-26 |
2005-08-11 |
Applera Corporation |
Methods, compositions, and kits for amplifying and sequencing polynucleotides
|
US7666592B2
(en)
|
2004-02-18 |
2010-02-23 |
Ibis Biosciences, Inc. |
Methods for concurrent identification and quantification of an unknown bioagent
|
WO2005080605A2
(en)
|
2004-02-19 |
2005-09-01 |
Helicos Biosciences Corporation |
Methods and kits for analyzing polynucleotide sequences
|
US8119336B2
(en)
|
2004-03-03 |
2012-02-21 |
Ibis Biosciences, Inc. |
Compositions for use in identification of alphaviruses
|
US7608394B2
(en)
|
2004-03-26 |
2009-10-27 |
Sequenom, Inc. |
Methods and compositions for phenotype identification based on nucleic acid methylation
|
US9249456B2
(en)
*
|
2004-03-26 |
2016-02-02 |
Agena Bioscience, Inc. |
Base specific cleavage of methylation-specific amplification products in combination with mass analysis
|
AU2005323451B2
(en)
|
2004-05-21 |
2010-11-18 |
Qiagen Sciences Llc |
Kits and processes for removing contaminants from nucleic acids in environmental and biological samples
|
WO2005117270A2
(en)
|
2004-05-24 |
2005-12-08 |
Isis Pharmaceuticals, Inc. |
Mass spectrometry with selective ion filtration by digital thresholding
|
US20050266411A1
(en)
|
2004-05-25 |
2005-12-01 |
Hofstadler Steven A |
Methods for rapid forensic analysis of mitochondrial DNA
|
WO2005118856A1
(en)
*
|
2004-05-27 |
2005-12-15 |
Sequenom, Inc. |
Methods for identifying risk of breast cancer and treatments thereof
|
US7811753B2
(en)
|
2004-07-14 |
2010-10-12 |
Ibis Biosciences, Inc. |
Methods for repairing degraded DNA
|
WO2006112869A2
(en)
*
|
2004-07-19 |
2006-10-26 |
Baylor College Of Medicine |
Modulation of cytokine signaling regulators and applications for immunotherapy
|
WO2006022628A1
(en)
*
|
2004-07-22 |
2006-03-02 |
Sequenom, Inc. |
Methods for identifying risk of type ii diabetes and treatments thereof
|
US20060073501A1
(en)
*
|
2004-09-10 |
2006-04-06 |
Van Den Boom Dirk J |
Methods for long-range sequence analysis of nucleic acids
|
US7678824B2
(en)
|
2004-09-14 |
2010-03-16 |
The Regents Of The University Of Colorado, A Body Corporate |
Methods for treatment with bucindolol based on genetic targeting
|
WO2006089152A2
(en)
*
|
2005-02-18 |
2006-08-24 |
Maxcyte, Inc. |
Use of methyltransferase inhibitors to enhance transgene expression
|
US20060205040A1
(en)
|
2005-03-03 |
2006-09-14 |
Rangarajan Sampath |
Compositions for use in identification of adventitious viruses
|
US8084207B2
(en)
|
2005-03-03 |
2011-12-27 |
Ibis Bioscience, Inc. |
Compositions for use in identification of papillomavirus
|
US20060286006A1
(en)
*
|
2005-06-21 |
2006-12-21 |
Mcdaniel C S |
Method and apparatus for the treatment of fluid waste streams
|
US7868159B2
(en)
*
|
2005-06-23 |
2011-01-11 |
Baylor College Of Medicine |
Modulation of negative immune regulators and applications for immunotherapy
|
CA2616281C
(en)
|
2005-07-21 |
2014-04-22 |
Isis Pharmaceuticals, Inc. |
Methods for rapid identification and quantitation of mitochondrial dna variants
|
US20070026012A1
(en)
|
2005-08-01 |
2007-02-01 |
Cornell Research Foundation, Inc. |
Compositions and methods for monitoring and altering protein folding and solubility
|
US7666593B2
(en)
|
2005-08-26 |
2010-02-23 |
Helicos Biosciences Corporation |
Single molecule sequencing of captured nucleic acids
|
US8980246B2
(en)
|
2005-09-07 |
2015-03-17 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus cancer therapy
|
WO2008019162A2
(en)
|
2006-01-18 |
2008-02-14 |
University Of Chicago |
Compositions and methods related to staphylococcal bacterium proteins
|
US7397546B2
(en)
|
2006-03-08 |
2008-07-08 |
Helicos Biosciences Corporation |
Systems and methods for reducing detected intensity non-uniformity in a laser beam
|
WO2007118222A2
(en)
|
2006-04-06 |
2007-10-18 |
Ibis Biosciences, INC |
Compositions for the use in identification of fungi
|
US8298818B2
(en)
*
|
2006-04-28 |
2012-10-30 |
University Of Florida Research Foundation, Inc. |
Self-complementary adeno-associated virus having a truncated CMV-chicken β-actin promoter
|
EP3260556B1
(de)
|
2006-05-31 |
2019-07-31 |
Sequenom, Inc. |
Verfahren zur nukleinsäureextraktion aus einer probe
|
US7479550B2
(en)
*
|
2006-06-02 |
2009-01-20 |
The Board Of Regents Of The University Of Texas System |
Amyloid β gene vaccines
|
EP2035439A4
(de)
|
2006-06-05 |
2010-01-13 |
Cancer Care Ontario |
Abschätzung des risikos von colorectalkrebs
|
EP2069791B1
(de)
|
2006-07-27 |
2012-01-25 |
University of Maryland, Baltimore |
Zellulärer rezeptor für antiproliferativen faktor
|
US9149473B2
(en)
|
2006-09-14 |
2015-10-06 |
Ibis Biosciences, Inc. |
Targeted whole genome amplification method for identification of pathogens
|
EP2064229B1
(de)
|
2006-09-15 |
2015-08-12 |
Ottawa Hospital Research Institute |
Onkolytisches rhabdovirus
|
CA2670967C
(en)
|
2006-11-29 |
2016-05-10 |
University Of Iowa Research Foundation |
Alternative export pathways for vector expressed rna interference
|
EP2102239B1
(de)
|
2006-11-30 |
2012-04-25 |
Research Development Foundation |
Verbesserte immunglobulin-bibliotheken
|
US7902345B2
(en)
|
2006-12-05 |
2011-03-08 |
Sequenom, Inc. |
Detection and quantification of biomolecules using mass spectrometry
|
WO2008098142A2
(en)
|
2007-02-08 |
2008-08-14 |
Sequenom, Inc. |
Nucleic acid-based tests for rhd typing, gender determination and nucleic acid quantification
|
US8871471B2
(en)
|
2007-02-23 |
2014-10-28 |
Ibis Biosciences, Inc. |
Methods for rapid forensic DNA analysis
|
CA2679954A1
(en)
|
2007-03-05 |
2008-09-12 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
WO2008118988A1
(en)
|
2007-03-26 |
2008-10-02 |
Sequenom, Inc. |
Restriction endonuclease enhanced polymorphic sequence detection
|
WO2008118324A2
(en)
|
2007-03-26 |
2008-10-02 |
Macrogenics, Inc. |
Composition and method of treating cancer with an anti-uroplakin ib antibody
|
DK2155789T3
(da)
|
2007-05-01 |
2013-10-21 |
Res Dev Foundation |
Immunoglobulin-Fc-biblioteker
|
US20100291544A1
(en)
*
|
2007-05-25 |
2010-11-18 |
Ibis Biosciences, Inc. |
Compositions for use in identification of strains of hepatitis c virus
|
WO2008151023A2
(en)
|
2007-06-01 |
2008-12-11 |
Ibis Biosciences, Inc. |
Methods and compositions for multiple displacement amplification of nucleic acids
|
US20110045456A1
(en)
*
|
2007-06-14 |
2011-02-24 |
Ibis Biosciences, Inc. |
Compositions for use in identification of adventitious contaminant viruses
|
EP2195452B1
(de)
|
2007-08-29 |
2012-03-14 |
Sequenom, Inc. |
Verfahren und zusammensetzungen für die universelle grössenspezifische polymerasekettenreaktion
|
WO2009039122A2
(en)
|
2007-09-17 |
2009-03-26 |
Sequenom, Inc. |
Integrated robotic sample transfer device
|
US8450106B2
(en)
*
|
2007-10-17 |
2013-05-28 |
The Ohio State University Research Foundation |
Oncolytic virus
|
US9518097B2
(en)
*
|
2007-11-09 |
2016-12-13 |
Board Of Trustees Of Michigan State University |
Identification and use of genes encoding amatoxin and phallotoxin
|
US9273100B2
(en)
|
2007-11-09 |
2016-03-01 |
Board Of Trustees Of Michigan State University |
Use of Galerina marginata genes and proteins for peptide production
|
JP2011505144A
(ja)
*
|
2007-11-30 |
2011-02-24 |
ベイラー カレッジ オブ メディシン |
樹状細胞ワクチン組成物およびその使用
|
JP5677703B2
(ja)
|
2008-01-10 |
2015-02-25 |
リサーチ ディベロップメント ファウンデーション |
Ehrlichiachaffeensisにのためのワクチンおよび診断
|
WO2009131728A2
(en)
*
|
2008-01-29 |
2009-10-29 |
Ibis Biosciences, Inc. |
Compositions for use in identification of picornaviruses
|
WO2009114543A2
(en)
|
2008-03-11 |
2009-09-17 |
Sequenom, Inc. |
Nucleic acid-based tests for prenatal gender determination
|
CA2718137A1
(en)
|
2008-03-26 |
2009-10-01 |
Sequenom, Inc. |
Restriction endonuclease enhanced polymorphic sequence detection
|
US8450112B2
(en)
|
2008-04-09 |
2013-05-28 |
Maxcyte, Inc. |
Engineering and delivery of therapeutic compositions of freshly isolated cells
|
US20110177515A1
(en)
*
|
2008-05-30 |
2011-07-21 |
Ibis Biosciences, Inc. |
Compositions for use in identification of francisella
|
WO2009155103A2
(en)
*
|
2008-05-30 |
2009-12-23 |
Ibis Biosciences, Inc. |
Compositions for use in identification of tick-borne pathogens
|
US20110151437A1
(en)
*
|
2008-06-02 |
2011-06-23 |
Ibis Biosciences, Inc. |
Compositions for use in identification of adventitious viruses
|
KR101871192B1
(ko)
|
2008-06-04 |
2018-06-27 |
후지필름 셀룰러 다이내믹스, 인코포레이티드 |
비-바이러스 접근법을 사용한 iPS 세포의 생산 방법
|
EP2331696A1
(de)
|
2008-08-12 |
2011-06-15 |
Cellular Dynamics International, Inc. |
Verfahren zur herstellung von ips-zellen
|
EP2328603A4
(de)
|
2008-08-18 |
2013-01-02 |
Univ Maryland |
Apf-derivate und verwendungsverfahren
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
US8476013B2
(en)
*
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
US8148163B2
(en)
|
2008-09-16 |
2012-04-03 |
Ibis Biosciences, Inc. |
Sample processing units, systems, and related methods
|
WO2010033599A2
(en)
|
2008-09-16 |
2010-03-25 |
Ibis Biosciences, Inc. |
Mixing cartridges, mixing stations, and related kits, systems, and methods
|
WO2010033625A1
(en)
|
2008-09-16 |
2010-03-25 |
Ibis Biosciences, Inc. |
Microplate handling systems and related computer program products and methods
|
US20110189687A1
(en)
*
|
2008-10-02 |
2011-08-04 |
Ibis Bioscience, Inc. |
Compositions for use in identification of members of the bacterial genus mycoplasma
|
US20110200985A1
(en)
*
|
2008-10-02 |
2011-08-18 |
Rangarajan Sampath |
Compositions for use in identification of herpesviruses
|
US20110183346A1
(en)
*
|
2008-10-03 |
2011-07-28 |
Ibis Biosciences, Inc. |
Compositions for use in identification of neisseria, chlamydia, and/or chlamydophila bacteria
|
WO2010039763A2
(en)
*
|
2008-10-03 |
2010-04-08 |
Ibis Biosciences, Inc. |
Compositions for use in identification of antibiotic-resistant bacteria
|
WO2010039775A1
(en)
*
|
2008-10-03 |
2010-04-08 |
Ibis Biosciences, Inc. |
Compositions for use in identification of members of the bacterial class alphaproteobacter
|
US20110183344A1
(en)
*
|
2008-10-03 |
2011-07-28 |
Rangarajan Sampath |
Compositions for use in identification of clostridium difficile
|
US20110183345A1
(en)
*
|
2008-10-03 |
2011-07-28 |
Ibis Biosciences, Inc. |
Compositions for use in identification of streptococcus pneumoniae
|
AU2009302582A1
(en)
|
2008-10-06 |
2010-04-15 |
University Of Chicago |
Compositions and methods related to bacterial Eap, Emp, and/or AdsA proteins
|
WO2010075441A1
(en)
|
2008-12-22 |
2010-07-01 |
Trustees Of Boston University |
Modular nucleic acid-based circuits for counters, binary operations, memory, and logic
|
US8388904B1
(en)
|
2008-12-22 |
2013-03-05 |
Reactive Surfaces, Ltd., Llp |
Equipment decontamination system and method
|
JP2012517238A
(ja)
|
2009-02-11 |
2012-08-02 |
カリス エムピーアイ インコーポレイテッド |
腫瘍の分子プロファイリング法
|
WO2010093943A1
(en)
|
2009-02-12 |
2010-08-19 |
Ibis Biosciences, Inc. |
Ionization probe assemblies
|
WO2010104798A1
(en)
|
2009-03-08 |
2010-09-16 |
Ibis Biosciences, Inc. |
Bioagent detection methods
|
WO2010107946A2
(en)
*
|
2009-03-18 |
2010-09-23 |
Sequenom, Inc. |
Use of thermostable endonucleases for generating reporter molecules
|
US9393564B2
(en)
|
2009-03-30 |
2016-07-19 |
Ibis Biosciences, Inc. |
Bioagent detection systems, devices, and methods
|
WO2010115016A2
(en)
|
2009-04-03 |
2010-10-07 |
Sequenom, Inc. |
Nucleic acid preparation compositions and methods
|
HUE026855T2
(en)
|
2009-04-03 |
2016-07-28 |
Univ Chicago |
Preparations and method for Protein A (SPA) variants
|
CN102459575A
(zh)
|
2009-06-05 |
2012-05-16 |
细胞动力国际有限公司 |
重编程t细胞和造血细胞的方法
|
EP2449104B1
(de)
|
2009-06-29 |
2014-06-04 |
Luminex Corporation |
Chimäre primer mit haarnadel-konformationen und verwendungsverfahren dafür
|
EP2454000A4
(de)
|
2009-07-17 |
2016-08-10 |
Ibis Biosciences Inc |
Systeme zur identifizierung von biowirkstoffen
|
WO2011008971A1
(en)
|
2009-07-17 |
2011-01-20 |
Ibis Biosciences, Inc. |
Lift and mount apparatus
|
US9409983B2
(en)
|
2009-07-23 |
2016-08-09 |
The Board Of Trustess Of The University Of Illinois |
Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
|
WO2011014811A1
(en)
*
|
2009-07-31 |
2011-02-03 |
Ibis Biosciences, Inc. |
Capture primers and capture sequence linked solid supports for molecular diagnostic tests
|
US9080209B2
(en)
|
2009-08-06 |
2015-07-14 |
Ibis Biosciences, Inc. |
Non-mass determined base compositions for nucleic acid detection
|
CA2772298A1
(en)
|
2009-08-26 |
2011-03-03 |
Research Development Foundation |
Methods for creating antibody libraries
|
US20110065111A1
(en)
*
|
2009-08-31 |
2011-03-17 |
Ibis Biosciences, Inc. |
Compositions For Use In Genotyping Of Klebsiella Pneumoniae
|
WO2011032088A1
(en)
|
2009-09-11 |
2011-03-17 |
Arca Biopharma, Inc. |
Polymorphisms in the pde3a gene
|
CN107303302A
(zh)
|
2009-09-14 |
2017-10-31 |
希拉金股份有限公司 |
溶瘤牛痘病毒组合癌症疗法
|
US9808504B2
(en)
|
2009-09-22 |
2017-11-07 |
Yale University |
Immunogenic epitopes as targets for universal cancer vaccines
|
EP2488656B1
(de)
|
2009-10-15 |
2015-06-03 |
Ibis Biosciences, Inc. |
Mehrfache verschiebungsverstärkung
|
EP2494077A4
(de)
|
2009-10-27 |
2013-08-21 |
Caris Mpi Inc |
Molekulare profilierung für personalisierte medizin
|
WO2011062962A2
(en)
|
2009-11-17 |
2011-05-26 |
The Trustees Of The University Of Pennsylvania |
Smndelta7 degron: novel compositions and methods of use
|
MX337062B
(es)
|
2009-12-10 |
2016-02-11 |
Ottawa Hospital Res Inst |
Rabdovirus oncolítico.
|
DK2516680T3
(en)
|
2009-12-22 |
2016-05-02 |
Sequenom Inc |
Method and kits to identify aneuploidy
|
ES2587191T3
(es)
|
2009-12-23 |
2016-10-21 |
Arca Biopharma, Inc. |
Métodos y composiciones para enfermedades y afecciones cardiovasculares
|
US10080799B2
(en)
|
2010-02-12 |
2018-09-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods and compositions related to glycoprotein-immunoglobulin fusions
|
US8774488B2
(en)
|
2010-03-11 |
2014-07-08 |
Cellscape Corporation |
Method and device for identification of nucleated red blood cells from a maternal blood sample
|
US9758840B2
(en)
*
|
2010-03-14 |
2017-09-12 |
Ibis Biosciences, Inc. |
Parasite detection via endosymbiont detection
|
CA2793424A1
(en)
|
2010-03-18 |
2011-09-22 |
Cornell University |
Engineering correctly folded antibodies using inner membrane display of twin-arginine translocation intermediates
|
JP2013523818A
(ja)
|
2010-04-05 |
2013-06-17 |
ザ・ユニバーシティー・オブ・シカゴ |
免疫反応のエンハンサーとしてのプロテインA(SpA)抗体に関連する組成物および方法
|
US10787701B2
(en)
|
2010-04-05 |
2020-09-29 |
Prognosys Biosciences, Inc. |
Spatially encoded biological assays
|
US20190300945A1
(en)
|
2010-04-05 |
2019-10-03 |
Prognosys Biosciences, Inc. |
Spatially Encoded Biological Assays
|
US8785385B2
(en)
|
2010-04-19 |
2014-07-22 |
Research Development Foundation |
RTEF-1 variants and uses thereof
|
ES2670842T3
(es)
|
2010-06-15 |
2018-06-01 |
Cellular Dynamics International, Inc. |
Generación de células madre pluripotentes inducidas a partir de pequeños volúmenes de sangre periférica
|
EP2588120B1
(de)
|
2010-07-02 |
2017-11-15 |
The University of Chicago |
Zusammensetzungen und verfahren bezüglich protein-a (spa)-varianten
|
JP5897002B2
(ja)
|
2010-07-07 |
2016-04-13 |
セルラー ダイナミクス インターナショナル, インコーポレイテッド |
プログラミングによる内皮細胞の産生
|
EP2596128B1
(de)
|
2010-07-22 |
2015-04-22 |
President and Fellows of Harvard College |
Biologische klassierschaltungen mit mehrfacheingabe für zellen
|
US8765470B2
(en)
|
2010-08-04 |
2014-07-01 |
Cellular Dynamics International, Inc. |
Reprogramming immortalized B-cells to induced pluripotent stem cells
|
EP2613791A4
(de)
|
2010-09-08 |
2015-05-13 |
Univ Texas |
Somatostatin-rezeptor-basierte krebstherapie
|
US9095540B2
(en)
|
2010-09-09 |
2015-08-04 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens
|
KR101942237B1
(ko)
|
2011-01-04 |
2019-01-25 |
신라젠(주) |
종양 항원에 대한 항체의 생산 및 종양용해 우두 바이러스의 투여에 의한 종양 특이적 보체 의존적 세포독성의 생산
|
WO2012109133A1
(en)
|
2011-02-07 |
2012-08-16 |
Research Development Foundation |
Engineered immunoglobulin fc polypeptides
|
US9574179B2
(en)
|
2011-02-08 |
2017-02-21 |
Cellular Dynamics International, Inc. |
Hematopoietic precursor cell production by programming
|
EP2681566A2
(de)
|
2011-02-28 |
2014-01-08 |
University of Iowa Research Foundation |
Anti-müller-hormon-veränderungen in der schwangerschaft und vorhersage von schwangerschaftsnebenwirkungen und des geschlechts
|
WO2012120377A2
(en)
|
2011-03-08 |
2012-09-13 |
King Abdullah University Of Science And Technology |
Molecular biomarker set for early detection of ovarian cancer
|
AU2012240395B2
(en)
|
2011-04-06 |
2016-02-04 |
The Board Of Regents Of The University Of Texas System |
Modulating bacterial MAM polypeptides in pathogenic disease
|
EP2694534B1
(de)
|
2011-04-08 |
2018-06-20 |
Evaxion Biotech ApS |
Proteine und nukleinsäuren zur verwendung für impstoffe gegen staphylococcus aureus
|
GB201106254D0
(en)
|
2011-04-13 |
2011-05-25 |
Frisen Jonas |
Method and product
|
SI2702146T1
(sl)
|
2011-04-28 |
2019-06-28 |
The Board Of Trustees Of The Leland Stanford Junior University |
Identifikacija polinukleotidov, povezanih z vzorcem
|
WO2012149339A2
(en)
|
2011-04-29 |
2012-11-01 |
Sequenom, Inc. |
Quantification of a minority nucleic acid species
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
EP2718427B1
(de)
|
2011-06-08 |
2017-01-11 |
Children's Hospital of Eastern Ontario Research Institute Inc. |
Zusammensetzungen zur behandlung von glioblastomen
|
EP2732029B1
(de)
|
2011-07-11 |
2019-01-16 |
FUJIFILM Cellular Dynamics, Inc. |
Verfahren zur zellprogrammierung und genommanipulation
|
US9446112B2
(en)
|
2011-07-12 |
2016-09-20 |
Philadelphia Health & Education Corporation |
Clostridium difficile DNA vaccine
|
US20130101664A1
(en)
|
2011-08-18 |
2013-04-25 |
Donald W. Kufe |
Muc1 ligand traps for use in treating cancers
|
US10040853B2
(en)
|
2011-09-09 |
2018-08-07 |
Fred Hutchinson Cancer Research Center |
Methods and compositions involving NKG2D inhibitors and cancer
|
EP2766388A1
(de)
|
2011-10-12 |
2014-08-20 |
Møller, Niels Iversen |
Peptide aus campylobacter jejuni und ihre verwendung bei der impfung
|
WO2013096798A2
(en)
|
2011-12-22 |
2013-06-27 |
Ibis Biosciences, Inc. |
Amplification of a sequence from a ribonucleic acid
|
EP2809783A2
(de)
|
2012-02-02 |
2014-12-10 |
Invenra, Inc. |
Hochdurchsatz-screen für biologisch aktive polypeptide
|
AU2013214776B2
(en)
|
2012-02-02 |
2017-11-09 |
Board Of Regents, The University Of Texas System |
Adenoviruses expressing heterologous tumor-associated antigens
|
US9605313B2
(en)
|
2012-03-02 |
2017-03-28 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
WO2013155439A1
(en)
|
2012-04-13 |
2013-10-17 |
Massachusetts Institute Of Technology |
Analog and mixed-signal computation and circuits in living cells
|
EP2844275B1
(de)
|
2012-04-26 |
2020-05-13 |
University of Chicago |
Staphylokokken-coagulase-antigene und verfahren zu deren verwendung
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
WO2014011928A1
(en)
|
2012-07-13 |
2014-01-16 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
WO2014039513A2
(en)
|
2012-09-04 |
2014-03-13 |
The Trustees Of The University Of Pennsylvania |
Inhibition of diacylglycerol kinase to augment adoptive t cell transfer
|
WO2014065945A1
(en)
|
2012-10-23 |
2014-05-01 |
The Board Of Regents Of The University Of Texas System |
Antibodies with engineered igg fc domains
|
CA2894710A1
(en)
|
2012-12-13 |
2014-06-19 |
Massachusetts Institute Of Technology |
Recombinase-based logic and memory systems
|
WO2014116721A1
(en)
|
2013-01-22 |
2014-07-31 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Geminiviral vector for expression of rituximab
|
US9896728B2
(en)
|
2013-01-29 |
2018-02-20 |
Arcticrx Ltd. |
Method for determining a therapeutic approach for the treatment of age-related macular degeneration (AMD)
|
CA2901501C
(en)
|
2013-02-21 |
2023-03-07 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
Vaccine composition
|
US20140242595A1
(en)
|
2013-02-22 |
2014-08-28 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
WO2014138315A1
(en)
|
2013-03-05 |
2014-09-12 |
Baylor College Of Medicine |
Heparanase expression in human t lymphocytes
|
ES2681948T3
(es)
|
2013-03-05 |
2018-09-17 |
Baylor College Of Medicine |
Células de acoplamiento para inmunoterapia
|
EP2964753B1
(de)
|
2013-03-07 |
2018-04-25 |
Baylor College of Medicine |
Targeting von cd138 bei krebs
|
KR102092435B1
(ko)
|
2013-03-08 |
2020-03-24 |
예일 유니버시티 |
피부색소침착 감소용 조성물 및 방법
|
US20160015750A1
(en)
|
2013-03-09 |
2016-01-21 |
Baylor College Of Medicine |
Vascular-targeted t-cell therapy
|
EP3597774A1
(de)
|
2013-03-13 |
2020-01-22 |
Sequenom, Inc. |
Primer zur analyse der dna-methylierung
|
US9718858B2
(en)
|
2013-03-13 |
2017-08-01 |
Trustees Of Boston University |
Tunable control of protein degradation in synthetic and endogenous bacterial systems
|
WO2014210223A1
(en)
|
2013-06-25 |
2014-12-31 |
Prognosys Biosciences, Inc. |
Spatially encoded biological assays using a microfluidic device
|
ES2902386T1
(es)
|
2013-07-01 |
2022-03-28 |
Massachusetts Inst Technology |
Funcionalización de bacterias endógenas
|
DK3041498T3
(da)
|
2013-09-05 |
2022-05-09 |
Massachusetts Inst Technology |
Afstemning af mikrobielle populationer med programmerbare nukleaser
|
CN105636614A
(zh)
|
2013-09-09 |
2016-06-01 |
菲格内有限责任公司 |
用于软骨细胞或软骨型细胞再生的基因治疗
|
SG11201602540XA
(en)
|
2013-10-03 |
2016-04-28 |
Oklahoma Med Res Found |
Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
|
US20170002064A1
(en)
|
2013-11-08 |
2017-01-05 |
The Board Of Regents Of The University Of Texas System |
Vh4 antibodies against gray matter neuron and astrocyte
|
WO2015070050A1
(en)
|
2013-11-08 |
2015-05-14 |
Baylor Research Institute |
Nuclear loclization of glp-1 stimulates myocardial regeneration and reverses heart failure
|
DK3071697T3
(da)
|
2013-11-22 |
2020-01-27 |
Dnatrix Inc |
Adenovirus der udtrykker immuncelle-stimulatorisk(e) receptor agonist(er)
|
EP3074025A1
(de)
|
2013-11-27 |
2016-10-05 |
Baylor College Of Medicine |
Csgp4-spezifischer chimärer antigenrezeptor für krebs
|
EP3077820A1
(de)
|
2013-12-03 |
2016-10-12 |
Evaxion Biotech ApS |
Proteine und nukleinsäuren zur verwendung für impfstoffe gegen staphylococcus aureus
|
US9512406B2
(en)
|
2013-12-20 |
2016-12-06 |
The J. David Gladstone Institute, a testamentary trust established under the Will of J. David Gladstone |
Generating hepatocytes
|
ES2912183T3
(es)
|
2013-12-30 |
2022-05-24 |
Atreca Inc |
Análisis de ácidos nucleicos asociados a células individuales utilizando códigos de barras de ácidos nucleicos
|
KR102448454B1
(ko)
|
2014-01-29 |
2022-09-28 |
다나-파버 캔서 인스티튜트 인크. |
Muc1-c/세포외 도메인 (muc1-c/ecd)에 대한 항체
|
WO2015117033A2
(en)
|
2014-01-31 |
2015-08-06 |
Biogen Ma Inc. |
Methods of increasing protein production in mammalian cells
|
EP3117011B1
(de)
|
2014-03-13 |
2020-05-06 |
Sequenom, Inc. |
Verfahren und prozesse zur nicht-invasiven beurteilung genetischer variationen
|
WO2015164228A1
(en)
|
2014-04-21 |
2015-10-29 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
US9737598B2
(en)
|
2014-06-30 |
2017-08-22 |
Regents Of The University Of Minnesota |
CD200 inhibitors and methods of use thereof
|
WO2016011343A1
(en)
|
2014-07-17 |
2016-01-21 |
The Trustees Of The University Of Pennsylvania |
Her3 peptides and dendritic cell vaccines
|
ES2844700T3
(es)
|
2014-09-26 |
2021-07-22 |
Baylor College Medicine |
Receptores quiméricos de antígeno específicos de glipicano-3 para inmunoterapia adoptiva
|
EP3218002B1
(de)
|
2014-11-13 |
2020-08-19 |
Evaxion Biotech ApS |
Aus acinetobacter baumannii abgeleitete peptide und deren verwendung bei der impfung
|
CA2969145A1
(en)
|
2014-11-26 |
2016-06-02 |
The Regents Of The University Of California |
Therapeutic compositions comprising transcription factors and methods of making and using the same
|
AU2015364240A1
(en)
|
2014-12-19 |
2017-06-08 |
Dana-Farber Cancer Institute, Inc. |
Carbonic anhydrase IX specific chimeric antigen receptors and methods of use thereof
|
MA41346A
(fr)
|
2015-01-12 |
2017-11-21 |
Juno Therapeutics Inc |
Eléments régulateurs post-transcriptionnels d'hépatite modifiée
|
EP3485907B1
(de)
|
2015-01-12 |
2023-06-28 |
Evaxion Biotech ApS |
Behandlung und prophylaxe von k.-pneumoniae-infektionen
|
MA41433A
(fr)
|
2015-01-26 |
2017-12-05 |
Baylor College Medicine |
Cellules immunitaires universelles pour l'immunothérapie anticancéreuse
|
US20180002656A1
(en)
|
2015-01-28 |
2018-01-04 |
Sabic Global Technologies B.V. |
Methods and compositions for high-efficiency production of biofuel and/or biomass
|
CA2976236A1
(en)
|
2015-02-09 |
2016-08-18 |
Research Development Foundation |
Engineered immunoglobulin fc polypeptides displaying improved complement activation
|
US11421229B2
(en)
|
2015-02-20 |
2022-08-23 |
Baylor College Of Medicine |
p63 inactivation for the treatment of heart failure
|
EP3070178B1
(de)
|
2015-03-20 |
2020-02-12 |
Albert-Ludwigs-Universität Freiburg |
Verfahren zur diagnose von brustkrebs
|
CN107532207B
(zh)
|
2015-04-10 |
2021-05-07 |
空间转录公司 |
生物样本的空间区别、多重核酸分析
|
WO2016172606A1
(en)
|
2015-04-23 |
2016-10-27 |
Baylor College Of Medicine |
Cd5 chimeric antigen receptor for adoptive t cell therapy
|
CA2988196C
(en)
|
2015-05-04 |
2021-04-27 |
The Brigham And Women's Hospital, Inc. |
Oncolytic hsv1 vector and methods of use
|
WO2017004579A1
(en)
|
2015-07-01 |
2017-01-05 |
O'connor Colleen M |
Artificial antigen presenting cells for adoptive cell therapy against cancer
|
EP3317295B1
(de)
|
2015-07-04 |
2022-05-18 |
Evaxion Biotech A/S |
Proteine und nukleinsäuren, die in impfstoffen gegen pseudomonas aeruginosa nützlich sind
|
WO2017040380A2
(en)
|
2015-08-28 |
2017-03-09 |
Research Development Foundation |
Engineered antibody fc variants
|
US11459573B2
(en)
|
2015-09-30 |
2022-10-04 |
Trustees Of Boston University |
Deadman and passcode microbial kill switches
|
CA3001518A1
(en)
|
2015-10-16 |
2017-04-20 |
Astrazeneca Ab |
Inducible modification of a cell genome
|
AU2016342179B2
(en)
|
2015-10-20 |
2022-08-18 |
FUJIFILM Cellular Dynamics, Inc. |
Multi-lineage hematopoietic precursor cell production by genetic programming
|
WO2017075421A1
(en)
|
2015-10-29 |
2017-05-04 |
Temple University-Of The Commonwealth System Of Higher Education |
Modification of 3' terminal ends of nucleic acids by dna polymerase theta
|
CN108463548B
(zh)
|
2015-10-30 |
2023-04-18 |
加利福尼亚大学董事会 |
由干细胞产生t细胞的方法及使用所述t细胞的免疫治疗方法
|
KR20180095511A
(ko)
|
2015-10-30 |
2018-08-27 |
더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 |
표적화된 암 요법
|
SI3370733T1
(sl)
|
2015-11-02 |
2021-11-30 |
Board Of Regents The University Of Texas System |
Postopek za aktivacijo CD40 in blokada imunske nadzorne točke
|
US10888609B2
(en)
|
2015-11-03 |
2021-01-12 |
Regents Of The University Of Minnesota |
CD200 inhibitors and methods of use thereof
|
AU2016349632A1
(en)
|
2015-11-07 |
2018-05-24 |
Multivir Inc. |
Compositions comprising tumor suppressor gene therapy and immune checkpoint blockade for the treatment of cancer
|
US11814440B2
(en)
|
2015-11-09 |
2023-11-14 |
The Children's Hospital Of Philadelphia |
Glypican 2 as a cancer marker and therapeutic target
|
CN108431226A
(zh)
|
2016-01-15 |
2018-08-21 |
阿斯利康(瑞典)有限公司 |
基因修饰测定
|
CA3013479A1
(en)
|
2016-02-16 |
2017-08-24 |
Carl NOVINA |
Immunotherapy compositions and methods
|
US20190160098A1
(en)
|
2016-02-16 |
2019-05-30 |
Dana-Farber Cancer Institute, Inc. |
Chimeric antigen receptors and methods of use thereof
|
EP3419654B1
(de)
|
2016-02-22 |
2022-04-27 |
Evaxion Biotech A/S |
In impfstoffen gegen staphylococcus aureus nützliche proteine und nukleinsäuren
|
EP3436049B1
(de)
|
2016-03-31 |
2022-01-12 |
Baylor Research Institute |
Angiopoietin-ähnliches protein 8 (angptl8)
|
EP3448369A4
(de)
|
2016-04-29 |
2020-01-01 |
The Regents of The University of Colorado, A Body Corporate |
Verbindungen und zusammensetzungen zur behandlung des stoffwechselsyndroms und verfahren damit
|
JP7099967B2
(ja)
|
2016-07-01 |
2022-07-12 |
リサーチ ディベロップメント ファウンデーション |
幹細胞由来移植片からの増殖性細胞の排除
|
MA45783A
(fr)
|
2016-07-29 |
2019-06-05 |
Juno Therapeutics Inc |
Procédés d'évaluation de la présence ou de l'absence d'un virus compétent pour la réplication
|
US9963498B2
(en)
|
2016-08-18 |
2018-05-08 |
Wisconsin Alumni Research Foundation |
Peptides that inhibit syndecan-1 activation of VLA-4 and IGF-1R
|
US11208664B2
(en)
|
2016-09-12 |
2021-12-28 |
Massachusetts Institute Of Technology |
Transcriptional sensor for bile acids in bacteroides thetaiotaomicron
|
JP7248571B2
(ja)
|
2016-10-05 |
2023-03-29 |
フジフィルム セルラー ダイナミクス,インコーポレイテッド |
MeCP2が破壊された誘導多能性幹細胞からの成熟系列の生成
|
BR112019006910A2
(pt)
|
2016-10-05 |
2019-07-02 |
Fujifilm Cellular Dynamics Inc |
métodos para diferenciação dirigida de células-tronco pluripotentes para células imunes homozigóticas de hla
|
WO2018081535A2
(en)
|
2016-10-28 |
2018-05-03 |
Massachusetts Institute Of Technology |
Dynamic genome engineering
|
JP2020500020A
(ja)
|
2016-11-14 |
2020-01-09 |
ノバルティス アーゲー |
融合誘導性タンパク質minionに関連する組成物、方法、および治療上の使用
|
KR20190112263A
(ko)
|
2016-12-12 |
2019-10-04 |
멀티비르 인코포레이티드 |
암 및 감염성 질환의 치료 및 예방을 위한 바이러스 유전자 치료요법 및 면역 체크포인트 억제제를 포함하는 방법 및 조성물
|
EP3565576A1
(de)
|
2017-01-05 |
2019-11-13 |
Evaxion Biotech ApS |
Impfstoffe gegen pseudomonas aeruginosa
|
US20190390278A1
(en)
|
2017-01-26 |
2019-12-26 |
Oklahoma Medical Research Foundation |
Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
|
US20200063127A1
(en)
|
2017-02-15 |
2020-02-27 |
Massachusetts Institute Of Technology |
Dna writers, molecular recorders and uses thereof
|
US11718860B2
(en)
|
2017-03-13 |
2023-08-08 |
Massachusetts Institute Of Technology |
Synthetic promoters
|
CN110612110A
(zh)
|
2017-03-17 |
2019-12-24 |
森迪生物科学公司 |
免疫调节细胞回路
|
US20200016207A1
(en)
|
2017-03-20 |
2020-01-16 |
Baylor College Of Medicine |
TRANSGENIC c-MPL PROVIDES LIGAND-DEPENDENT CO-STIMULATION AND CYTOKINE SIGNALS TO TCR-ENGINEERED T CELLS
|
US20180291443A1
(en)
*
|
2017-04-11 |
2018-10-11 |
Nugen Technologies, Inc. |
Library Quantitation And Qualification
|
KR20190141695A
(ko)
|
2017-04-13 |
2019-12-24 |
센티 바이오사이언시스, 인코포레이티드 |
병용 암 면역요법
|
US20200123501A1
(en)
|
2017-04-18 |
2020-04-23 |
FUJIFILM Cellular Dynamics, Inc. |
Antigen-specific immune effector cells
|
JP2020530986A
(ja)
|
2017-07-27 |
2020-11-05 |
ノバルティス アーゲー |
シェダーゼ耐性trem2変異体
|
WO2019027869A1
(en)
|
2017-07-31 |
2019-02-07 |
Massachusetts Institute Of Technology |
RNA-CLUSTER INDUCED TRANSCRIPT STABILIZER AND USES THEREOF
|
WO2019027414A1
(en)
|
2017-07-31 |
2019-02-07 |
Massachusetts Institute Of Technology |
HIGH PERFORMANCE MULTIPLE INPUT MICRO-RNA DETECTORS AND USES THEREOF
|
CA3089834A1
(en)
|
2018-01-30 |
2019-08-08 |
Children's Medical Center Corporation |
Production of botulinum neurotoxins using bacillus systems
|
JP2021511802A
(ja)
|
2018-01-31 |
2021-05-13 |
ジュノー セラピューティクス インコーポレイテッド |
複製可能ウイルスの存在または非存在を評価するための方法および試薬
|
AU2019322487B2
(en)
|
2018-03-19 |
2024-04-18 |
Multivir Inc. |
Methods and compositions comprising tumor suppressor gene therapy and CD122/CD132 agonists for the treatment of cancer
|
EP3787748A1
(de)
|
2018-05-01 |
2021-03-10 |
OrfoNeuro ApS |
Behandlung von neuronaler ceroid-lipofuszinose
|
UY38247A
(es)
|
2018-05-30 |
2019-12-31 |
Novartis Ag |
Anticuerpos frente a entpd2, terapias de combinación y métodos de uso de los anticuerpos y las terapias de combinación
|
WO2020028609A1
(en)
|
2018-08-01 |
2020-02-06 |
Massachusetts Institute Of Technology |
Phosphorylation-based mirna sensor
|
WO2020028612A1
(en)
|
2018-08-01 |
2020-02-06 |
Massachusetts Institute Of Technology |
Rna-based regulatory technologies for mirna sensors
|
KR20210102870A
(ko)
|
2018-08-30 |
2021-08-20 |
테나야 테라퓨틱스, 인코포레이티드 |
미오카르딘 및 ascl1을 사용한 심장 세포 재프로그래밍
|
UY38407A
(es)
|
2018-10-15 |
2020-05-29 |
Novartis Ag |
Anticuerpos estabilizadores de trem2
|
CA3116539C
(en)
|
2018-10-18 |
2023-10-03 |
Oklahoma Medical Research Foundation |
Biomarkers for a systemic lupus erythematosus (sle) disease activity immune index that characterizes disease activity
|
WO2020083904A1
(en)
|
2018-10-22 |
2020-04-30 |
Evaxion Biotech Aps |
Vaccines targeting m. catharrhalis
|
WO2020113237A1
(en)
|
2018-11-30 |
2020-06-04 |
Caris Mpi, Inc. |
Next-generation molecular profiling
|
WO2020123319A2
(en)
|
2018-12-10 |
2020-06-18 |
10X Genomics, Inc. |
Methods of using master / copy arrays for spatial detection
|
US11926867B2
(en)
|
2019-01-06 |
2024-03-12 |
10X Genomics, Inc. |
Generating capture probes for spatial analysis
|
EP3931206A1
(de)
|
2019-02-27 |
2022-01-05 |
Evaxion Biotech ApS |
Impfstoffe gegen h. influenzae
|
US20200283796A1
(en)
|
2019-03-05 |
2020-09-10 |
Massachusetts Institute Of Technology |
Dna launched rna replicon system (drep) and uses thereof
|
EP3938524A1
(de)
|
2019-03-14 |
2022-01-19 |
Massachusetts Institute of Technology |
Manipulierte herpes-simplex-virus-1 (hsv-1)-vektoren und ihre verwendungen
|
US20200325472A1
(en)
|
2019-04-09 |
2020-10-15 |
Massachusetts Institute Of Technology |
Mutant subgenomic promoter library and uses thereof
|
WO2020236597A1
(en)
|
2019-05-17 |
2020-11-26 |
Massachusetts Institute Of Technology |
Engineered post-poly a signal rna and uses thereof
|
EP3976820A1
(de)
|
2019-05-30 |
2022-04-06 |
10X Genomics, Inc. |
Verfahren zum nachweis der räumlichen heterogenität einer biologischen probe
|
WO2021007515A1
(en)
|
2019-07-11 |
2021-01-14 |
Tenaya Therapeutics, Inc. |
Cardiac cell reprogramming with micrornas and other factors
|
CN114555807A
(zh)
|
2019-07-19 |
2022-05-27 |
费城儿童医院 |
包含磷脂酰肌醇蛋白聚糖2结合结构域的嵌合抗原受体
|
EP3772543B1
(de)
|
2019-08-09 |
2023-09-27 |
Albert-Ludwigs-Universität Freiburg |
Verfahren zur diagnose von brustkrebs
|
US20220333132A1
(en)
|
2019-09-03 |
2022-10-20 |
Sana Blotechnology, Inc. |
Cd24-associated particles and related methods and uses thereof
|
AU2020342668A1
(en)
|
2019-09-06 |
2022-03-03 |
Generation Bio Co. |
Lipid nanoparticle compositions comprising closed-ended DNA and cleavable lipids and methods of use thereof
|
WO2021048381A1
(en)
|
2019-09-13 |
2021-03-18 |
Evaxion Biotech Aps |
Method for identifying stable mhc binding peptides using mass spectrometry
|
US20220334129A1
(en)
|
2019-09-13 |
2022-10-20 |
Evaxion Biotech A/S |
Method for identifying T-cell epitopes
|
TW202124446A
(zh)
|
2019-09-18 |
2021-07-01 |
瑞士商諾華公司 |
與entpd2抗體之組合療法
|
JP2022548881A
(ja)
|
2019-09-18 |
2022-11-22 |
ノバルティス アーゲー |
Entpd2抗体、組合せ療法並びに抗体及び組合せ療法を使用する方法
|
WO2021062092A1
(en)
|
2019-09-26 |
2021-04-01 |
Massachusetts Institute Of Technology |
Trans-activated functional rna by strand displacement and uses thereof
|
WO2021062096A1
(en)
|
2019-09-26 |
2021-04-01 |
Massachusetts Institute Of Technology |
Microrna-based logic gates and uses thereof
|
CA3155930A1
(en)
|
2019-09-27 |
2021-04-01 |
Starkage Therapeutics |
SENESCENT CELL-ASSOCIATED ANTIGEN-BINDING DOMAINS, ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS COMPRISING THEM, AND USES THEREOF
|
KR20220103968A
(ko)
|
2019-11-22 |
2022-07-25 |
제너레이션 바이오 컴퍼니 |
이온화 가능한 지질 및 이의 나노입자 조성물
|
EP4069865A4
(de)
|
2019-12-02 |
2023-12-20 |
Caris MPI, Inc. |
Platinresistenztest für pan-krebs
|
WO2021113644A1
(en)
|
2019-12-05 |
2021-06-10 |
Multivir Inc. |
Combinations comprising a cd8+ t cell enhancer, an immune checkpoint inhibitor and radiotherapy for targeted and abscopal effects for the treatment of cancer
|
US20230008380A1
(en)
|
2019-12-09 |
2023-01-12 |
University Of Georgia Research Foundation, Inc. |
M. tuberculosis ag85 proteins and methods of use
|
WO2021140123A1
(en)
|
2020-01-06 |
2021-07-15 |
Evaxion Biotech Aps |
Vaccines targeting neisseria gonorrhoeae
|
US11898205B2
(en)
|
2020-02-03 |
2024-02-13 |
10X Genomics, Inc. |
Increasing capture efficiency of spatial assays
|
US11891654B2
(en)
|
2020-02-24 |
2024-02-06 |
10X Genomics, Inc. |
Methods of making gene expression libraries
|
EP4110904A1
(de)
|
2020-02-28 |
2023-01-04 |
Takeda Pharmaceutical Company Limited |
Verfahren zur herstellung natürlicher killerzellen aus pluripotenten stammzellen
|
AU2021230476A1
(en)
|
2020-03-02 |
2022-10-20 |
Tenaya Therapeutics, Inc. |
Gene vector control by cardiomyocyte-expressed microRNAs
|
CN115667530A
(zh)
|
2020-03-24 |
2023-01-31 |
世代生物公司 |
非病毒dna载体和其用于表达因子ix治疗剂的用途
|
CA3172591A1
(en)
|
2020-03-24 |
2021-09-30 |
Douglas Anthony KERR |
Non-viral dna vectors and uses thereof for expressing gaucher therapeutics
|
EP4127148A1
(de)
|
2020-03-25 |
2023-02-08 |
Erasmus University Rotterdam Medical Center |
Reportersystem zur radionuklidbildgebung
|
MX2022012191A
(es)
|
2020-03-31 |
2023-01-05 |
Sana Biotechnology Inc |
Partículas lipídicas dirigidas y composiciones y usos de estas.
|
EP4242325A3
(de)
|
2020-04-22 |
2023-10-04 |
10X Genomics, Inc. |
Verfahren zur räumlichen analyse unter verwendung von gezieltem rna-abbau
|
US20230190871A1
(en)
|
2020-05-20 |
2023-06-22 |
Sana Biotechnology, Inc. |
Methods and compositions for treatment of viral infections
|
WO2021236929A1
(en)
|
2020-05-22 |
2021-11-25 |
10X Genomics, Inc. |
Simultaneous spatio-temporal measurement of gene expression and cellular activity
|
WO2021237087A1
(en)
|
2020-05-22 |
2021-11-25 |
10X Genomics, Inc. |
Spatial analysis to detect sequence variants
|
CN116033912A
(zh)
|
2020-05-29 |
2023-04-28 |
富士胶片细胞动力公司 |
视网膜色素上皮和感光器双细胞聚集物及其使用方法
|
IL298254A
(en)
|
2020-05-29 |
2023-01-01 |
Fujifilm Cellular Dynamics Inc |
Double layer of retinal pigment epithelium and photoreceptors and their uses
|
US11761038B1
(en)
|
2020-07-06 |
2023-09-19 |
10X Genomics, Inc. |
Methods for identifying a location of an RNA in a biological sample
|
JP2023540705A
(ja)
|
2020-08-28 |
2023-09-26 |
サナ バイオテクノロジー,インコーポレイテッド |
修飾された抗ウイルス結合剤
|
US11926822B1
(en)
|
2020-09-23 |
2024-03-12 |
10X Genomics, Inc. |
Three-dimensional spatial analysis
|
US11781156B2
(en)
|
2020-10-09 |
2023-10-10 |
Tenaya Therapeutics, Inc. |
Plakophillin-2 gene therapy methods and compositions
|
US11827935B1
(en)
|
2020-11-19 |
2023-11-28 |
10X Genomics, Inc. |
Methods for spatial analysis using rolling circle amplification and detection probes
|
WO2022120019A2
(en)
|
2020-12-02 |
2022-06-09 |
Massachusetts Institute Of Technology |
A tunable phosphorylation-based feedback controller of mammalian gene expression
|
AU2021409136A1
(en)
|
2020-12-21 |
2023-06-29 |
10X Genomics, Inc. |
Methods, compositions, and systems for capturing probes and/or barcodes
|
US20240110160A1
(en)
|
2021-01-15 |
2024-04-04 |
Board Of Regents, The University Of Texas System |
A trans-complementation system for sars-cov-2
|
CA3202849A1
(en)
|
2021-02-09 |
2022-08-18 |
University Of Houston System |
Oncolytic virus for systemic delivery and enhanced anti-tumor activities
|
AU2022264509A1
(en)
|
2021-04-27 |
2023-12-14 |
Generation Bio Co. |
Non-viral dna vectors expressing therapeutic antibodies and uses thereof
|
WO2022232286A1
(en)
|
2021-04-27 |
2022-11-03 |
Generation Bio Co. |
Non-viral dna vectors expressing anti-coronavirus antibodies and uses thereof
|
EP4334437A1
(de)
|
2021-05-03 |
2024-03-13 |
Astellas Institute for Regenerative Medicine |
Verfahren zur erzeugung reifer hornhautendothelzellen
|
WO2022235940A1
(en)
|
2021-05-06 |
2022-11-10 |
Dana-Farber Cancer Institute, Inc. |
Antibodies against alk and methods of use thereof
|
EP4334435A1
(de)
|
2021-05-07 |
2024-03-13 |
Astellas Institute for Regenerative Medicine |
Verfahren zur erzeugung reifer hepatozyten
|
US20220389436A1
(en)
|
2021-05-26 |
2022-12-08 |
FUJIFILM Cellular Dynamics, Inc. |
Methods to prevent rapid silencing of genes in pluripotent stem cells
|
EP4347623A1
(de)
|
2021-05-26 |
2024-04-10 |
Evaxion Biotech A/S |
Impfung gegen intrazelluläre pathogene
|
CN117642420A
(zh)
|
2021-05-28 |
2024-03-01 |
萨那生物科技公司 |
含有截短的狒狒内源性逆转录病毒(BaEV)包膜糖蛋白的脂质颗粒及相关方法和用途
|
EP4355727A1
(de)
|
2021-06-14 |
2024-04-24 |
Generation Bio Co. |
Kationische lipide und zusammensetzungen daraus
|
CN117813374A
(zh)
|
2021-06-15 |
2024-04-02 |
武田药品工业株式会社 |
从多能干细胞产生自然杀伤细胞的方法
|
WO2023280807A1
(en)
|
2021-07-05 |
2023-01-12 |
Evaxion Biotech A/S |
Vaccines targeting neisseria gonorrhoeae
|
WO2023034489A1
(en)
|
2021-09-01 |
2023-03-09 |
10X Genomics, Inc. |
Methods, compositions, and kits for blocking a capture probe on a spatial array
|
TW202342498A
(zh)
|
2021-12-17 |
2023-11-01 |
美商薩那生物科技公司 |
經修飾副黏液病毒科融合醣蛋白
|
WO2023114543A2
(en)
|
2021-12-17 |
2023-06-22 |
Dana-Farber Cancer Institute, Inc. |
Platform for antibody discovery
|
WO2023115041A1
(en)
|
2021-12-17 |
2023-06-22 |
Sana Biotechnology, Inc. |
Modified paramyxoviridae attachment glycoproteins
|
WO2023114544A1
(en)
|
2021-12-17 |
2023-06-22 |
Dana-Farber Cancer Institute, Inc. |
Antibodies and uses thereof
|
WO2023172694A1
(en)
|
2022-03-09 |
2023-09-14 |
Dana-Farber Cancer Institute, Inc. |
Genetically engineered b cells and methods of use thereof
|
WO2023177655A1
(en)
|
2022-03-14 |
2023-09-21 |
Generation Bio Co. |
Heterologous prime boost vaccine compositions and methods of use
|
US20230295661A1
(en)
|
2022-03-16 |
2023-09-21 |
University Of Houston System |
Persistent hsv gene delivery system
|
WO2023201207A1
(en)
|
2022-04-11 |
2023-10-19 |
Tenaya Therapeutics, Inc. |
Adeno-associated virus with engineered capsid
|
WO2023215860A1
(en)
|
2022-05-05 |
2023-11-09 |
University Of Rochester |
Modified bacteria and methods of use for bioglass microlenses
|
WO2023214346A1
(en)
|
2022-05-06 |
2023-11-09 |
Novartis Ag |
Novel recombinant aav vp2 fusion polypeptides
|
US20240010742A1
(en)
|
2022-06-10 |
2024-01-11 |
Research Development Foundation |
Engineered fcriib selective igg1 fc variants and uses thereof
|
WO2024006911A1
(en)
|
2022-06-29 |
2024-01-04 |
FUJIFILM Holdings America Corporation |
Ipsc-derived astrocytes and methods of use thereof
|
WO2024040222A1
(en)
|
2022-08-19 |
2024-02-22 |
Generation Bio Co. |
Cleavable closed-ended dna (cedna) and methods of use thereof
|
WO2024064838A1
(en)
|
2022-09-21 |
2024-03-28 |
Sana Biotechnology, Inc. |
Lipid particles comprising variant paramyxovirus attachment glycoproteins and uses thereof
|
WO2024081820A1
(en)
|
2022-10-13 |
2024-04-18 |
Sana Biotechnology, Inc. |
Viral particles targeting hematopoietic stem cells
|